Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model

被引:25
|
作者
Naito, Yoshiro [1 ]
Fujii, Aya [1 ]
Sawada, Hisashi [1 ]
Hirotani, Shinichi [1 ]
Iwasaku, Toshihiro [1 ]
Okuhara, Yoshitaka [1 ]
Eguchi, Akiyo [1 ]
Ohyanagi, Mitsumasa [2 ]
Tsujino, Takeshi [3 ]
Masuyama, Tohru [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan
[3] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan
关键词
chronic kidney disease; hypertension; iron; mineralocorticoid receptor; BLOOD-PRESSURE; RAC1; GTPASE; ACCUMULATION; HYPERTENSION; ANGIOTENSIN; INHIBITION;
D O I
10.1097/HJH.0b013e328360381d
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: Iron accumulation is associated with the pathogenesis of chronic kidney disease (CKD). However, little is known about the effects of isolated iron restriction against CKD. We have recently reported that iron restriction prevents the development of renal damage in the well established 5/6 nephrectomy rat model of CKD. Herein, we investigated the therapeutic effects of iron restriction on preexisting hypertension and renal damage in a rat model of CKD. Methods: CKD was induced by 5/6 nephrectomy in Sprague-Dawley rats. After surgery, 5/6 nephrectomized rats were given an iron-restricted diet from 1 day to 16 weeks for prevention protocol or from 8 to 16 weeks for rescue protocol. Other CKD rats were given a normal diet. Results: At 16 weeks after surgery, CKD rats developed hypertension and renal damage. Early intervention with iron restriction prevented the development of hypertension and vascular remodeling. By contrast, late intervention with iron restriction did not remarkably ameliorate preexisting hypertension and vascular remodeling in CKD rats. On the contrary, late intervention with iron restriction prevented further progression of preexisting renal damage in CKD rats. Interestingly, iron restriction led to increased urinary sodium and decreased urinary potassium excretions in CKD rats. Moreover, iron restriction markedly attenuated renal expression of nuclear mineralocorticoid receptor and Rac1 activity in CKD rats. Conclusion: Iron restriction prevented further deterioration of preexisting renal damage. The beneficial effects of iron restriction on renal damage seem to be associated with inhibition of renal mineralocorticoid receptor signaling.
引用
收藏
页码:1203 / 1213
页数:11
相关论文
共 50 条
  • [31] Normalization of Renal AT1 Receptor Expression is Observed With Enalapril But Not Diltiazem in a Rat Model of Chronic Kidney Disease
    Ismail, Basma
    deKemp, Rob A.
    Croteau, Etienne
    Hadizad, Tayebeh
    Burns, Kevin
    Beanlands, Rob S.
    DaSilva, Jean N.
    CIRCULATION, 2015, 132
  • [32] Indoxyl Sulfate Predicts Cardiovascular Disease and Renal Function Deterioration in Advanced Chronic Kidney Disease
    Lin, Cheng-Jui
    Liu, Hsuan-Liang
    Pan, Chi-Feng
    Chuang, Chih-Kuang
    Jayakumar, Thanasekaran
    Wang, Tuen-Jen
    Chen, Han-Hsiang
    Wu, Chih-Jen
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (06) : 451 - 456
  • [33] Determinants of renal tissue hypoxia in a rat model of polycystic kidney disease
    Ow, Connie P. C.
    Abdelkader, Amany
    Hilliard, Lucinda M.
    Phillips, Jacqueline K.
    Evans, Roger G.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2014, 307 (10) : R1207 - R1215
  • [34] Ouabain Contributes to Kidney Damage in a Rat Model of Renal Ischemia-Reperfusion Injury
    Villa, Luca
    Buono, Roberta
    Ferrandi, Mara
    Molinari, Isabella
    Benigni, Fabio
    Bettiga, Arianna
    Colciago, Giorgia
    Ikehata, Masami
    Messaggio, Elisabetta
    Rastaldi, Maria Pia
    Montorsi, Francesco
    Salonia, Andrea
    Manunta, Paolo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10):
  • [35] Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease
    Bigelman, Einat
    Cohen, Lena
    Aharon-Hananel, Genya
    Levy, Ran
    Rozenbaum, Zach
    Saada, Ann
    Keren, Gad
    Entin-Meer, Michel
    PLOS ONE, 2018, 13 (06):
  • [36] Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease
    Katayama, Yuko
    Sugama, Jun
    Suzuki, Tomohisa
    Ishimura, Yoshimasa
    Kobayashi, Akihiro
    Moritoh, Yusuke
    Watanabe, Masanori
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (04) : 631 - 640
  • [37] Adipose triglyceride lipase protects renal cell endocytosis in a Drosophila dietary model of chronic kidney disease
    Lubojemska, Aleksandra
    Stefana, M. Irina
    Sorge, Sebastian
    Bailey, Andrew P.
    Lampe, Lena
    Yoshimura, Azumi
    Burrell, Alana
    Collinson, Lucy
    Gould, Alex P.
    PLOS BIOLOGY, 2021, 19 (05)
  • [38] L-Carnitine improves cognitive and renal functions in a rat model of chronic kidney disease
    Abu Ahmad, Nur
    Armaly, Zaher
    Berman, Sylvia
    Jabour, Adel
    Aga-Mizrachi, Shlomit
    Mosenego-Ornan, Efrat
    Avital, Avi
    PHYSIOLOGY & BEHAVIOR, 2016, 164 : 182 - 188
  • [39] Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure
    Soni, Hitesh M.
    Patel, Praful P.
    Patel, Savan
    Rath, Akshyaya C.
    Acharya, Aviseka
    Trivedi, Harshkant D.
    Jain, Mukul R.
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (01) : 80 - 85
  • [40] Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
    van Koppen, Arianne
    Papazova, Diana A.
    Oosterhuis, Nynke R.
    Gremmels, Hendrik
    Giles, Rachel H.
    Fledderus, Joost O.
    Joles, Jaap A.
    Verhaar, Marianne C.
    STEM CELL RESEARCH & THERAPY, 2015, 6